Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019Gregory A. Roth, Michael Pratt, George A. Mensah et al.|Journal of the American College of Cardiology|2020Cited by 11.1k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Mohammad H. Forouzanfar, Ashkan Afshin, Lily Alexander et al.|The Lancet|2016Cited by 7.8k
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, David R. Matthews, Vlado Perkovic et al.|New England Journal of Medicine|2017Cited by 7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesRohina Joshi, Anushka Patel, Stephen MacMahon et al.|New England Journal of Medicine|2008Cited by 7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Kenneth W. Mahaffey, Meg Jardine et al.|New England Journal of Medicine|2019Cited by 6k